Iran Develops Lipid Microbubbles to Enhance Ultrasound Imaging
WANA (Aug 26) – Researchers at the Institute of Biochemistry and Biophysics (IBB), University of Tehran, have developed lipid microbubbles as specialized contrast agents for ultrasound and echocardiography, significantly improving image clarity and enabling more accurate disease diagnosis. The project received support from the Iranian Nanotechnology Initiative Council.
Led by Dr. Mohammad Ali Khaiymian, the research team addressed a critical challenge in ultrasound imaging: low image contrast. In many cases, insufficient clarity forces physicians to rely on more invasive and expensive diagnostic procedures.
The team introduced a nanotechnology-based solution: core-shell lipid-gas microbubbles. These microbubbles, with high echogenicity, efficiently reflect ultrasound waves, enhancing image contrast.
Each microbubble has a gas core stabilized by a lipid shell and measures less than 10 microns, allowing safe passage through blood vessels. Their microscopic size ensures improved clarity and quality in ultrasound and echocardiography images, providing physicians with faster and more precise diagnostic capabilities.
Beyond enhancing image contrast, the use of lipid microbubbles can reduce the need for costly tests, minimize diagnostic errors, and save both time and treatment costs for patients. Under Dr. Khiamian’s supervision, the research team has successfully produced prototypes of these microbubbles. The primary advantage lies in the substantial improvement in medical image contrast, a factor that can meaningfully enhance disease diagnosis.
The target market includes radiology clinics and hospitals, which stand to directly benefit from higher-quality imaging. As most contrast agents in Iran are imported, this domestic achievement could reduce foreign dependency and strengthen the country’s knowledge-based economy. The Nanotechnology Initiative Council recognizes this project as product-oriented, and efforts to commercialize the technology are ongoing.
Researchers also highlight the broader potential of lipid microbubbles, including applications in targeted drug delivery and ultrasound-based therapies. This opens new avenues for interdisciplinary use of nano-biotechnology in modern medicine. With successful commercialization, Iran could emerge as a leader in nanotechnology-based contrast agents, advancing both diagnostic and therapeutic healthcare services.
The development of these lipid microbubbles marks a significant step toward improving medical imaging, offering patients faster, safer, and more cost-effective diagnostic solutions, while positioning Iran as a key innovator in nano-biomedical technology.
Iran Develops Lipid Microbubbles to Enhance Ultrasound Imaging. Social media/ WANA News Agency
